gallium ga-68 psma-11- gallium ga-68 gozetotide injection, solution
ucsf radiopharmaceutical facility - gallium ga-68 gozetotide (unii: zj0ekr6m10) (gallium ga-68 gozetotide - unii:zj0ekr6m10) - gallium ga 68 gozeotide injection is indicated for positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer: - with suspected metastasis who are candidates for initial definitive therapy. - with suspected recurrence based on elevated serum prostate-specific antigen (psa) level. none risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no available data with gallium ga 68 gozetotide injection use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. all radiopharmaceuticals, including gallium ga 68 gozetotide injection, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. animal reproduction studies have not been conducted with gallium ga 68 gozetotide injection. risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there ar
gallium citrate (ga 67) injection 37 mbqml
qt instruments (s) pte ltd - gallium citrate eqv ga67 - injection - 37 mbq/ml at art - gallium citrate eqv ga67 37 mbq/ml at art
gallium ga-68 psma-11- gallium ga-68 gozetotide injection, solution
ucla biomedical cyclotron - gallium ga-68 gozetotide (unii: zj0ekr6m10) (gallium ga-68 gozetotide - unii:zj0ekr6m10) - gallium ga 68 gozetotide injection is indicated for positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer: - with suspected metastasis who are candidates for initial definitive therapy. - with suspected recurrence based on elevated serum prostate-specific antigen (psa) level. none risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no available data with gallium ga 68 gozetotide injection use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. all radiopharmaceuticals, including gallium ga 68 gozetotide injection, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. animal reproduction studies have not been conducted with gallium ga 68 gozetotide. risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no data
thallous (tl201) chloride injection 37 mbq/ml solution for injection
curium netherlands b.v. - thallous chloride (201 tl) - solution for injection - 37 megabecquerel(s)/millilitre - other cardiovascular system diagnostic radiopharmaceuticals; thallium (201tl) chloride
gallium citrate (ga67) inj 37 mbqml (82 mbq)
quantarad technologies sdn bhd - gallium-67 -
gallium citrate (ga67) inj 37 mbqml (123 mbq)
quantarad technologies sdn bhd - gallium-67 -
gallium citrate (ga67) inj 37 mbqml (205 mbq)
quantarad technologies sdn bhd - gallium-67 -
dbl™ dobutamine hydrochloride
pfizer new zealand limited - dobutamine hydrochloride 12.5 mg/ml - solution for injection - 12.5 mg/ml - active: dobutamine hydrochloride 12.5 mg/ml excipient: sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. (refer to the data sheet for conditions which may precipitate such situations).
thallium chloride tl-201
isorad ltd, israel - thallium (201tl) chloride - solution for injection - thallium (201tl) chloride - other cardiovascular system diagnostic radiopharmaceuticals - myocardial perfusion imaging.
allium cepa liquid
deeplaid pharmaco ltd. (homoeo) - allium cepa - liquid